Posts in: perriman

PharmaSource podcast featuring EXOZ CCO, Perriman
investorpodcastperrimanNCT
PharmaSource podcast: How EXOZ Is Running a 10-CDMO RFP for CDMO SelectionSeptember 9, 2026
Dr. Paul Opgenorth from eXoZymes at Curia in Italy
investorperrimanNCT
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCTSeptember 8, 2026
WBMI: Scaling without Cells
investornutraceuticalspress clippingsperrimanNCT
World Bio Market Insights: Scaling without CellsSeptember 3, 2026
Q&A: Tyler Korman, Michael Heltzen, Damien Perriman
heltzeninvestorvideoperrimankorman
Transcript: Q2 2026 investor update from EXOZAugust 21, 2026
NCT process advances beyond original commercial-scale economic targets
press releaseinvestorscienceperrimanNCT
eXoZymes' NCT process achieves 10-fold productivity increase, advancing beyond original commercial-scale economic targetsAugust 18, 2026
Webull 'Biotech Sector' webinar by Perriman
investorpress clippingsvideopodcastperriman
Webull: 'Biotech Sector' webinar by Damien PerrimanJune 30, 2026
Ladder17 podcast: How eXoZymes is Scaling as a Public Company
nutraceuticalspress clippingspodcastperrimanNCT
Ladder17 podcast: How eXoZymes is Scaling as a Public CompanyJune 25, 2026
Webull Biotech Sector Webinar
investorperriman
CCO of eXoZymes, Perriman, to present at Webull's 'Biotech Sector' webinarJune 18, 2026
Damien Perriman interviewed for Springwise
press clippingsperrimanNCT
Springwise case study: Unpacking how eXoZymes and Cayman Chemical are rethinking chemical manufacturingApril 17, 2026
Grow Everything podcast featuring Damien Perriman
press releasenutraceuticalsmedicinepress clippingsvideosciencepodcastperrimanNCT
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcastApril 10, 2026
Previous page
Page 1 of 3
Next page